Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
2007
An Open-Label, Randomized Study Comparing Efficacy and Safety of Intravenous Piperacillin/Tazobactam and Ampicillin/Sulbactam for Infected Diabetic Foot Ulcers
2005
Pathogens Isolated From Deep Soft Tissue and Bone in Patients With Diabetic Foot Infections
2008
Infective Endocarditis
2005 Standout
Incidence, Etiology, and Antibiotic Resistance Patterns of Gram-Negative Microorganisms Isolated from Patients with Ventilator-Associated Pneumonia in a Medical-Surgical Intensive Care Unit of a Teaching Hospital in Istanbul, Turkey (2004-2006)
2008
Molecular Epidemiology of Community-Associated Antimicrobial-Resistant Staphylococcus aureus in Seoul, Korea (2003): Pervasiveness of Multidrug-Resistant SCC mec Type II Methicillin-Resistant S. aureus
2007
Prevalence of nosocomial infections at intensive care units in Turkey: A multicentre 1-day point prevalence study
2004
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem
2013
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
1999
Vulvovaginal candidosis
2007 Standout
The Impact of Penicillinase on Cefamandole Treatment and Prophylaxis of Experimental Endocarditis Due to Methicillin‐ResistantStaphylococcus aureus
1998
An Outbreak of Community-Onset Methicillin-ResistantStaphylococcus aureusSkin Infections in Southwestern Alaska
2003
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
2006
Daily antibiotic cost of nosocomial infections in a Turkish university hospital
2005
Magnetic Resonance Imaging for Diagnosing Foot Osteomyelitis
2007
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Glucan synthase inhibitors as antifungal agents
2001
Antimicrobial-Drug Resistance
1996
Brucellosis: an Overview
1997 Standout
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Evidence-based antibiotic therapy of diabetic foot infections
1999
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
2002
Brucellosis
2005 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study
2007
Risk factors for developing osteomyelitis in patients with diabetic foot wounds
2008
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
The Science of Antibiotic Discovery
2020 Standout
Management of multidrug-resistant enterococcal infections
2010
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
The Basis for Resistance to β-Lactam Antibiotics by Penicillin-binding Protein 2a of Methicillin-resistant Staphylococcus aureus
2004
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
An Overview of Human Brucellosis
1995 Standout
The 2.4-Å crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Sepsis and septic shock
2018 Standout
Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy
1997
Multiplicity of Genetic Backgrounds among VancomycinResistant Enterococcus faecium Isolates Recovered from an Outbreak in a New York City Hospital
1996
Echinocandin antifungal drugs
2003 Standout
Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials
1997
The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting
2009
Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment
2008
Successful Treatment of Persistent Bacteremia due to Vancomycin-Resistant, Ampicillin-Resistant Enterococcus faecium
1995
Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study
2003
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† †This study was presented, in part, at the 37th ICAAC in Toronto, Canada, 28th September – 1st October 1997.
2001
Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome
2005
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Factors Predicting and Reducing Mortality in Patients with Invasive Staphylococcus aureus Disease in a Developing Country
2009
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations
2006
Resistance to Glycopeptides in Enterococci
1997
Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males
2004
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
2008
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection
1996
Diagnostic Accuracy of the Physical Examination and Imaging Tests for Osteomyelitis Underlying Diabetic Foot Ulcers: Meta‐Analysis
2008
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
2006
Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC)
2007
Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China*
2007
Nosocomial Methicillin-ResistantStaphylococcus aureusBacteremia: Is It Any Worse Than Nosocomial Methicillin-SensitiveStaphylococcus aureusBacteremia?
2000
Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey
2003
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults
1997
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Recognition and Optimum Treatment of Brucellosis
1997
Infective Endocarditis Due to Unusual or Fastidious Microorganisms
1997
Methicillin-resistant Staphylococus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities
1997
Infective endocarditis
2004 Standout
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Epidemiologic Trend of Severe Sepsis in Taiwan From 1997 Through 2006
2010
vanA-mediated high-level glycopeptide resistance inEnterococcus faeciumfrom animal husbandry
1995
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysis
2003 Standout
Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen
2004
Predictive Value of The Rome Criteria for Diagnosing The Irritable Bowel Syndrome
1999
Staphylococcus aureusInfections
1998 Standout
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Versatility of Aminoglycosides and Prospects for Their Future
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
The epidemiology of sepsis in Colombia: A prospective multicenter cohort study in ten university hospitals*
2011
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Molecular imprinting science and technology: a survey of the literature for the years 2004-2011
2014
Dosage-Dependent Antifungal Efficacy of V-Echinocandin (LY303366) against Experimental Fluconazole-Resistant Oropharyngeal and Esophageal Candidiasis
2001
Diabetic foot osteomyelitis
2008
Irritable Bowel Syndrome
2015 Standout
Immunosenescence and Novel Vaccination Strategies for the Elderly
2013
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
2006
Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
2012
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing
1995 Standout
Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts
1998
Consensus PCR and Microarray for Diagnosis of the Genus Staphylococcus , Species, and Methicillin Resistance
2001
Effective treatments in the management of brucellosis
2005
Assessment of Clinical Criteria for Sepsis
2016 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
1994
Prevalence of Burnout in Medical and Surgical Residents: A Meta-Analysis
2019 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital
1997
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
In Vitro Activity of the Echinocandin Antifungal Agent LY303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp
1998
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
1997
Novel Fluorogenic Substrates for Imaging β-Lactamase Gene Expression
2003 StandoutNobel
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
LY303366 Exhibits Rapid and Potent Fungicidal Activity in Flow Cytometric Assays of Yeast Viability
1999
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Molecular imprinted nanosensor based on surface plasmon resonance: Application to the sensitive determination of amoxicillin
2014
Osteomyelitis in the diabetic patient: diagnosis and treatment. Part 2: Medical, surgical, and alternative treatments.
2001
Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing
1994
Seminar Review: A Review of the Basis of Surgical Treatment of Diabetic Foot Infections
2011
Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies
2005
Diagnosis and Treatment of Diabetic Foot Infections
2004
Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis
1997
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium
1997
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Predictors of Mortality in Staphylococcus aureus Bacteremia
2012
FemABX Peptidyl Transferases: a Link between Branched-Chain Cell Wall Peptide Formation and β-Lactam Resistance in Gram-Positive Cocci
2003
Epidemiology of sepsis in Colombian intensive care units.
2015
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers
2006
The rational development of molecularly imprinted polymer-based sensors for protein detection
2010
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium
2003
Biological identifications through DNA barcodes
2003 Standout
In vitro activities in new oxazolidinone antimicrobial agents against enterococci
1996
Probe-to-Bone Test for Diagnosing Diabetic Foot Osteomyelitis
2007
Molecular imprinting: perspectives and applications
2016 Standout
Works of Serhat Ünal being referenced
Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004
2005
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics
1999
Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country
2005
Factors Influencing Prognosis in Bacteremia Due to Gram-Negative Organisms: Evaluation of 448 Episodes in a Turkish University Hospital
1992
Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish University Hospital
2000
The organization of hospital infection control in Turkey
2002
The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey
2001
Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme
2004
A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common
2001
Comparison of the effect of closed versus open endotracheal suction systems on the development of ventilator-associated pneumonia
2004
Burnout syndrome during residency in internal medicine and pediatrics in a country without working time directive
2014
In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates
1993
Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases
2004
Production of surface plasmon resonance based assay kit for hepatitis diagnosis
2009
Characterization of vancomycin resistance in Enterococcus durans
1995
Efficacy of Sulbactam-Ampicillin for the Treatment of Severe Diabetic Foot Infections
1996
Cloning and characterization of femA and femB from Staphylococcus epidermidis
1996
The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning
2006
Economic Analysis of Nosocomial Infections in a Turkish University Hospital
1997
Site-directed mutagenesis of the mecA gene from a methicillin-resistant strain of Staphylococcus aureus
1994
Hepatitis B surface antibody purification with hepatitis B surface antibody imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-l-tyrosine methyl ester) particles
2008
Detection of methicillin-resistant staphylococci by using the polymerase chain reaction
1992
Kruis scoring system and Manning's criteria in diagnosis of irritable bowel syndrome: is it better to use combined?
1997
Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin
1993
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.
2012
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci
1993
[Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
2006
In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates
1997
Correlation of In Vitro Fluconazole Susceptibility with Clinical Outcome for Severely Ill Patients with Oropharyngeal Candidiasis
1998
Comparison of tests for detection of methicillin-resistant Staphylococcus aureus in a clinical microbiology laboratory
1994
New antimicrobial agents for the treatment of Gram-positive bacterial infections
2008